Cipher Pharmaceuticals (OTCMKTS:CPHRF) Shares Pass Above 50-Day Moving Average – What’s Next?

Cipher Pharmaceuticals Inc. (OTCMKTS:CPHRF) (TSE:CPH)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $11.04 and traded as high as $12.1660. Cipher Pharmaceuticals shares last traded at $11.9930, with a volume of 11,350 shares traded.

Cipher Pharmaceuticals Stock Performance

The business has a 50 day moving average of $11.04 and a 200 day moving average of $10.84.

Cipher Pharmaceuticals Company Profile

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company that develops, acquires and commercializes prescription products in respiratory and dermatology markets. Founded in 2004 and headquartered in Vancouver, British Columbia, the company focuses on in-licensing established therapies and launching them under its own commercial infrastructure in North America.

In the respiratory segment, Cipher markets generic inhalation therapies for conditions such as asthma and chronic obstructive pulmonary disease (COPD).